Intervacc AB
Edit

Intervacc AB

https://intervacc.se/
Last activity: 21.10.2024
Active
Categories: BioTechCareDevelopmentHealthTechManufacturingMedtechProductResearch
A new generation of vaccines within animal health We develop vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care, with a very good safety profile.
Followers
1.28K
Followers
556
Website visits
2.7K /mo.
Mentions
33
Location: Sweden, Stockholm
Employees: 11-50
Total raised: $4.4M

Funding Rounds 1

DateSeriesAmountInvestors
19.12.2010-$4.4M-

Mentions in press and media 33

DateTitleDescription
21.10.2024Out-of-stock situation regarding Strangvac in Sweden resolvedOut-of-stock situation regarding Strangvac in Sweden resolved Mon, Oct 21, 2024 16:10 CET Report this content Stockholm, October 21, 2024 – Intervacc AB (publ) announces that the shortage situation for the equine strangles vaccine Strangvac...
20.09.2024Intervacc identifies a potential short out-of-stock situation regarding StrangvacIntervacc identifies a potential short out-of-stock situation regarding Strangvac Fri, Sep 20, 2024 17:37 CET Report this content Stockholm, September 20, 2024 - Intervacc AB (publ) predicts that the vaccine Strangvac, which is approved for...
20.09.2024Extended Patent Protection for Strangvac approved in the United KingdomExtended Patent Protection for Strangvac approved in the United Kingdom Fri, Sep 20, 2024 08:30 CET Report this content Stockholm, September 20, 2024 – Intervacc AB (publ) announces that the application for supplementary protection for Stra...
29.08.2024Interim report January – June 2024Interim report January – June 2024 Thu, Aug 29, 2024 08:30 CET Report this content The Group in summary 01/04/24 01/04/23 01/01/24 01/01/23 Full year -30/06/24 -30/06/23 -30/06/24 -30/06/23 2023 Net sales 2 735 1 882 5 129 3 365 8 015 Opera...
21.08.2024Advancements in Animal Health: Intervacc and Karolinska Institutet's Innovative Vaccine DevelopmentIn the realm of animal health, innovation is a powerful ally. Intervacc AB, a Swedish company, is at the forefront of this revolution. Their partnership with the Karolinska Institutet (KI) has blossomed into a beacon of hope for animal welf...
20.08.2024European experts on equine strangles publish guidelines regarding vaccination with StrangvacEuropean experts on equine strangles publish guidelines regarding vaccination with Strangvac Tue, Aug 20, 2024 13:15 CET Report this content Stockholm, August 20, 2024 – Some of Europe's foremost strangles experts have compiled and publishe...
15.08.2024Intervacc and the Karolinska Institutet extends contract for the development of innovative animal health vaccinesIntervacc and the Karolinska Institutet extends contract for the development of innovative animal health vaccines Thu, Aug 15, 2024 09:30 CET Report this content Stockholm, August 15, 2024 –Intervacc AB (publ) and the Karolinska Institute, ...
31.07.2024Reduction of share capital registered by the Swedish Companies Registration OfficeReduction of share capital registered by the Swedish Companies Registration Office Wed, Jul 31, 2024 10:00 CET Report this content Stockholm, July 31, 2024 - Intervacc AB (publ) announces that the reduction of share capital and nominal valu...
13.06.2024Intervacc has presented new findings at the ACVIM Forum in the United StatesIntervacc has presented new findings at the ACVIM Forum in the United States Thu, Jun 13, 2024 11:15 CET Report this content Stockholm, June 13th, 2024 – Intervacc AB (publ) has presented new reports highlighting the importance of vaccinati...
15.05.2024Report from Annual General Meeting in IntervaccReport from Annual General Meeting in Intervacc Wed, May 15, 2024 14:30 CET Report this content Intervacc AB (publ) has held its Annual General Meeting (”AGM”) on Wednesday 15 May 2024, at which the following resolutions were made. Adoption...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In